The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First interim results of the Radium-223 (Ra-223) reassure observational study in metastatic castration-resistant prostate cancer (mCRPC): Safety and baseline (BL) characteristics of U.S. patients (Pts) by prior/concomitant treatment (Tx).
 
Lauren Christine Harshman
Consulting or Advisory Role - Corvus Pharmaceuticals; Dendreon; Genentech; KEW; Medivation/Astellas; Merck; NCCN; Pfizer; PlatformQ Health; Theragene
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology; Medivation/Astellas (Inst); Merck (Inst); Sotio (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Sanofi
 
A. Oliver Sartor
Consulting or Advisory Role - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Constellation Pharmaceuticals; Dendreon; Endocyte; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); InVitae (Inst); Johnson & Johnson (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals
 
Timothy Richardson
Honoraria - Astellas Pharma; Bayer
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
John Sylvester
Employment - 21st Century Oncology
Stock and Other Ownership Interests - Genomix
Honoraria - Genomix; Isoray
Consulting or Advisory Role - Theragenics
Speakers' Bureau - Genomix
Research Funding - Bayer; Isoray
Patents, Royalties, Other Intellectual Property - QLRAD
Travel, Accommodations, Expenses - QLRAD; Theragenics
 
Daniel Y. Song
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Constantine Mantz
Employment - 21st Century Oncology
 
Robert K. Brookland
Stock and Other Ownership Interests - Nymox
Honoraria - Bayer; Insys Therapeutics
Consulting or Advisory Role - Gerson Lehrman Group
Speakers' Bureau - Insys Therapeutics
Travel, Accommodations, Expenses - Bayer; Insys Therapeutics
 
Mark Perlmutter
No Relationships to Disclose
 
Robert Given
Honoraria - Healthtronics; Janssen
Speakers' Bureau - Janssen
Research Funding - Clovis Oncology; Ferring; Janssen
 
Jan Kalinovsky
Employment - Bayer
 
Svetlana Babajanyan
Employment - Bayer
 
Yoriko De Sanctis
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Celestia S. Higano
Employment - CTI (I)
Leadership - CTI (I)
Stock and Other Ownership Interests - CTI (I)
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Endocyte; Ferring; Medivation; MorphoSys; Myriad Genetics; Orion; Parexel
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Emergent BioSolutions; Endocyte; Ferring; Genentech; Menarini; Myriad Genetics; Orion